Official Title
The COVID-19 Mobile Health Study, a Large-scale Clinical Observational Study Using nCapp
Brief Summary

This study evaluates a brand-new cell phone-based auto-diagnosis system, which is based on the clinical guidelines, clinical experience, and statistic training model. We will achieve secure and 1st hand data from physicians in Wuhan, which including 150 cases in the training cohort and 300 cases in the validation cohort.

Unknown status
COVID-19

Other: nCapp, a cell phone-based auto-diagnosis system

Combined with 15 questions online, and a predicated formula to auto-diagnosis of the risk of COVID-19

Eligibility Criteria

Inclusion Criteria:

- High risk of COVID-19

- RT-PCR test result of SAR2-CoV-19

Exclusion Criteria:

- Not available for RT-PCR test result of SAR2-CoV-19

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 90 Years
Countries
China
Locations

Renmin Hospital of Wuhan University
Wuhan, Hubei, China

Investigator: Chunxue Bai

Investigator:

Contacts

Chunxue Bai
+8618621170011‬
bai.chunxue@zs-hospital.sh.cn

Dawei Yang
+8613564703813
yang.dawei@zs-hospital.sh.cn

Chunxue Bai, Principal Investigator
Shanghai Respiratory Research Institution

Shanghai Respiratory Research Institution
NCT Number
MeSH Terms
COVID-19